Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The role of the opioid system in controlling pain, reward and addiction is well established, but its role in regulating other emotional responses is poorly documented in pharmacology. The mu-, delta- and kappa- opioid receptors (encoded by Oprm, Oprd1 and Oprk1, respectively) mediate the biological activity of opioids. We have generated Oprd1-deficient mice and compared the behavioural responses of mice lacking Oprd1, Oprm (ref. 6) and Oprk1 (ref. 7) in several models of anxiety and depression. Our data show no detectable phenotype in Oprk1-/- mutants, suggesting that kappa-receptors do not have a role in this aspect of opioid function; opposing phenotypes in Oprm-/- and Oprd1-/- mutants which contrasts with the classical notion of similar activities of mu- and delta-receptors; and consistent anxiogenic- and depressive-like responses in Oprd1-/- mice, indicating that delta-receptor activity contributes to improvement of mood states. We conclude that the Oprd1-encoded receptor, which has been proposed to be a promising target for the clinical management of pain, should also be considered in the treatment of drug addiction and other mood-related disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, agonism of the delta-opioid receptor, the primary receptor target of enkephalin, promotes antidepressant outcomes (80), while delta receptor knockout promotes depressive-like behavior (81).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [81]
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Self-citationOpioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Self-citationTimpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W. (1998) · Nature Genetics · doi:10.1038/520 · Cited by 919
Lufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationDecreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550
Cited by
Items 401–500 of 692
Hemoglobin-derived peptides and mood regulation
Wei, F., Zhao, L., & Jing, Y. (2020) · Peptides · doi:10.1016/j.peptides.2020.170268 · Cited by 21
Dripps, I. J., Chen, R., Shafer, A. M., Livingston, K. E., Disney, A., Husbands, S. M., Traynor, J. R., Rice, K. C., & Jutkiewicz, E. M. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.262717 · Cited by 22
Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
Ferreira, C., de Almeida, M. C. M. D., Tenreiro, S., & Quintas, A. (2020) · Life · doi:10.3390/life10060086 · Cited by 22
Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Cameron, C. M., Nieto, S. J., Bosler, L., Wong, M. H., Bishop, I., Mooney, L. J., & Cahill, C. M. (2021) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2021.10009 · Cited by 20
Wand, G. S., Weerts, E. M., Kuwabara, H., Wong, D. F., Xu, X., & McCaul, M. E. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00430.x · Cited by 21
Affect-Related Behaviors in Mice Selectively Bred for High and Low Voluntary Alcohol Consumption
Can, A., Grahame, N. J., & Gould, T. D. (2011) · Behavior Genetics · doi:10.1007/s10519-011-9505-y · Cited by 21
Rezaï, X., Kieffer, B. L., Roux, M. J., & Massotte, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079081 · Cited by 20
Self-citationRoversi, K., Pase, C. S., Roversi, K., Vey, L. T., Dias, V. T., Metz, V. G., & Bürger, M. E. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.031 · Cited by 20
Yokota, E., Koyanagi, Y., Yamamoto, K., Oi, Y., Koshikawa, N., & Kobayashi, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.10.004 · Cited by 20
Delta Opioid Receptor Expression and Function in Primary Afferent Somatosensory Neurons
François, A., & Scherrer, G. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_58 · Cited by 24
Jardinaud, F., Crété, D., Canestrelli, C., Ledent, C. A., Roques, B. P., & Noble, F. (2005) · Brain Research · doi:10.1016/j.brainres.2005.09.015 · Cited by 20
Onali, P., & Olianas, M. C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301152 · Cited by 20
Loop Dialysis Catheter: A Technology for Chronic Spinal Dialysis in a Freely Moving Rat
Maršala, M. (2004) · Humana Press eBooks · doi:10.1385/1-59259-770-x:269 · Cited by 22
Jorm, A. F., Prior, M. R., Sanson, A. V., Smart, D., Zhang, Y., Tan, S. M. K., & Easteal, S. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10643 · Cited by 20
Tkaczynski, J. A., Borodovitsyna, O., & Chandler, D. J. (2022) · Brain Sciences · doi:10.3390/brainsci12070860 · Cited by 19
Viggiano, A., Cacciola, G., Widmer, D. A. J., & Viggiano, D. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.032 · Cited by 21
Kotlinska, J. H., Gibuła‐Tarłowska, E., Pachuta, A., Kunce, D., Witkowska, E., Chung, N. N., Schiller, P. W., & Izdebski, J. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833e7e97 · Cited by 20
Wang, Q., Long, Y., Hang, A., Zan, G., Shu, X. H., Wang, Y., & Liu, J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4292-z · Cited by 20
Antinociceptive Effects of Aaptamine, a Sponge Component, on Peripheral Neuropathy in Rats
Sung, C., Cheng, H., Chen, N., Tang, S.-H., Kuo, H., Sung, P., Chen, W.-F., & Wen, Z. (2023) · Marine Drugs · doi:10.3390/md21020113 · Cited by 19
Effects of oxycodone on brain responses to emotional images
Wardle, M. C., Fitzgerald, D. A., Angstadt, M., Rabinak, C. A., de Wit, H., & Phan, K. L. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3592-4 · Cited by 20
Callaghan, C. K., Rouine, J., Dean, R. L., Knapp, B. I., Bidlack, J. M., Deaver, D. R., & O’Mara, S. M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.08.016 · Cited by 21
Luo, R., Li, X., Qin, S., Luo, Z., Luo, X., Hu, P., Liu, Z., Feng, X., & Li, X. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0072 · Cited by 19
Sasaki, K., Sumiyoshi, A., Nonaka, H., Kasahara, Y., Ikeda, K., Hall, F. S., Uhl, G. R., Watanabe, M., Kawashima, R., & Sora, I. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12807 · Cited by 21
Opioid and placebo analgesia share the same network
Petrović, P. (2005) · Seminars in Pain Medicine · doi:10.1016/j.spmd.2005.02.005 · Cited by 20
Preproenkephalin Knockout Mice Show No Depression-Related Phenotype
Bilkei‐Gorzó, A., Michel, K., Noble, F., Roques, B. P., & Zimmer, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301370 · Cited by 19
Cooper, A. J., Rickels, K., & Lohoff, F. W. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2317 · Cited by 20
Martínez‐Navarro, M., Lara-Mayorga, I. M., Negrete, R., Bilecki, W., Wawrzczak‐Bargieła, A., Gonçalves, L., Dickenson, A. H., Przewłocki, R., Baños, J.-E., & Maldonado, R. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.012 · Cited by 18
Self-citationCaputi, F. F., Rullo, L., Stamatakos, S., Candeletti, S., & Romualdi, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164010 · Cited by 19
Opioid-dependent regulation of high and low fear responses in two inbred mouse strains
Szklarczyk, K., Korostyński, M., Cieślak, P. E., Wawrzczak‐Bargieła, A., & Przewłocki, R. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.06.001 · Cited by 20
Creson, T. K., Hao, Y., Engel, S. R., Shen, Y., Hamidi, A., Zhuo, M., Manji, H. K., & Chen, G. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00697.x · Cited by 18
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies
Vergura, R., Valenti, E., Hebbes, C. P., Gavioli, E. C., Spagnolo, B., McDonald, J. L., Lambert, D. G., Balboni, G., Salvadori, S., Regoli, D. C., et al. (2006) · Peptides · doi:10.1016/j.peptides.2006.07.015 · Cited by 20
Family 1 G protein-coupled receptor function in the CNS Insights from gene knockout mice
Karasinska, J. M., George, S. R., & O’Dowd, B. F. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00221-7 · Cited by 21
Advanced Transgenic Approaches to Understand Alcohol-Related Phenotypes in Animals
Bilbao, A. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_204 · Cited by 17
Sharafshah, A., Tolami, H. F., Albonaim, A., Omarmeli, V., Rezaei, S., Mirzajani, E., Ajamian, F., & Keshavarz, P. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1290303 · Cited by 17
Distinct Roles of Opioid and Dopamine Systems in Lateral Hypothalamic Intracranial Self-Stimulation
Ide, S., Takahashi, T., Takamatsu, Y., Uhl, G. R., Niki, H., Sora, I., & Ikeda, K. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw113 · Cited by 20
Polymorphism of Opioid Receptors μ1 in Highly Hypnotizable Subjects
Presciuttini, S., Curcio, M., Sciarrino, R., Scatena, F., Jensen, M. P., & Santarcangelo, E. L. (2018) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2018.1396128 · Cited by 19
DiCello, J. J., Carbone, S., Saito, A., Pham, V., Szymaszkiewicz, A., Gondin, A. B., Alvi, S., Marique, K., Shenoy, P. A., Veldhuis, N. A., et al. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00297.2021 · Cited by 17
Yoshioka, T., Yamada, D., Segi‐Nishida, E., Nagase, H., & Saitoh, A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109511 · Cited by 17
Brejchová, J., Vošahlíková, M., Roubalová, L., Parenti, M. D., Mauri, M., Chernyavskiy, O., & Svoboda, P. (2016) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-016-9667-7 · Cited by 17
Shared mechanisms of alcohol and other drugs.
(2008) · Europe PMC (PubMed Central) · Cited by 16
Yoshioka, T., Yamada, D., Hagiwara, A., Kajino, K., Iio, K., Saitoh, T., Nagase, H., & Saitoh, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02814-z · Cited by 16
Kremer, M., Megat, S., Bohren, Y., Wurtz, X., Nexon, L., Ceredig, R. A., Doridot, S., Massotte, D., Salvat, É., Yalçın, İ., et al. (2020) · Molecular Pain · doi:10.1177/1744806920912931 · Cited by 16
Sacharczuk, M., Leśniak, A., Lipkowski, A. W., Korostyński, M., Przewłocki, R., & Sadowski, B. (2013) · Addiction Biology · doi:10.1111/adb.12030 · Cited by 16
Koyama, T., Mayahara, T., Wakamatsu, T., Sora, I., & Fukuda, K. (2009) · British Journal of Anaesthesia · doi:10.1093/bja/aep246 · Cited by 16
Yokota, E., Koyanagi, Y., Nakamura, H., Horinuki, E., Oi, Y., & Kobayashi, M. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.065 · Cited by 16
Su, D., Wang, M., Ye, C., Fang, J., Duan, Y., Zhang, Z., Hua, Q., Shi, C., Zhang, L., Zhang, R., et al. (2017) · Scientific Reports · doi:10.1038/srep44476 · Cited by 16
Delta Opioids: Neuroprotective Roles in Preclinical Studies
Husain, S. (2018) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2017.0039 · Cited by 17
GPCR and Alcohol-Related Behaviors in Genetically Modified Mice
Neasta, J., Darcq, E., Jeanblanc, J., Carnicella, S., & Hamida, S. B. (2020) · Neurotherapeutics · doi:10.1007/s13311-019-00828-y · Cited by 17
Clarke, S., Chen, Z., Hsu, M.-S., Hill, R., Pintar, J. E., & Kitchen, I. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00750-9 · Cited by 16
Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality
Kelty, E. A., Hulse, G. K., Joyce, D. A., & Preen, D. B. (2020) · CNS Drugs · doi:10.1007/s40263-020-00719-3 · Cited by 17
Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals
Price, R. C., Christou, N. V., Backman, S. B., Stone, L. S., & Schweinhardt, P. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4417-4 · Cited by 16
Ross, R., Mandelblat-Cerf, Y., & Verstegen, A. M. J. (2016) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000111 · Cited by 18
Deletion of mu opioid receptors reduces palatable solution intake in a mouse model of binge eating
Awad, G., Roeckel, L.-A., Massotte, D., Olmstead, M. C., & Befort, K. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000496 · Cited by 15
Self-citationZozulya, A. A., Кост, Н. В., Sokolov, O. Y., Gabaeva, M. V., Grivennikov, I. A., Andreeva, L. N., Zolotarev, Y. A., Иванов, С. В., Andryushchenko, A. V., Myasoedov, N. F., et al. (2001) · Bulletin of Experimental Biology and Medicine · doi:10.1023/a:1017979514274 · Cited by 15
Carroll, F. I., Zhang, L., Mascarella, S. W., Navarro, H. A., Rothman, R. B., Cantrell, B. E., Zimmerman, D. M., & Thomas, J. B. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030419a · Cited by 15
Rosa, S. G., Pesarico, A. P., Martini, F., & Nogueira, C. W. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1024-x · Cited by 15
Delta Opioid Receptor-Mediated Antidepressant-Like Effects of Diprenorphine in Mice
Olson, K. M., Hillhouse, T. M., Burgess, G. E., West, J. L., Hallahan, J. E., Dripps, I. J., Ladetto, A. G., Rice, K. C., Jutkiewicz, E. M., & Traynor, J. R. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001182 · Cited by 14
Schlussman, S. D., Cassin, J., Zhang, Y., Levran, O., Ho, A., & Kreek, M. J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.07.013 · Cited by 15
Mitchell, J., Margolis, E. B., Coker, A. R., & Fields, H. L. (2012) · Behavioral Neuroscience · doi:10.1037/a0029027 · Cited by 16
Zhang, Y., Braithwaite, A., Yuan, Y., Streicher, J. M., & Bilsky, E. J. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.04.041 · Cited by 15
Mahoney, M. K., Silveira, M. M., & Olmstead, M. C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3190-x · Cited by 14
Antiallodynic action of phosphodiesterase inhibitors in a mouse model of peripheral nerve injury
Megat, S., Hugel, S., Journée, S. H., Bohren, Y., Lacaud, A., Lelièvre, V., Doridot, S., Villa, P., Bourguignon, J., Salvat, É., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108909 · Cited by 15
Knockout Mouse Models in Pain Research
Dierich, A., & Kieffer, B. L. (2004) · Humana Press eBooks · doi:10.1385/1-59259-770-x:167 · Cited by 21
Self-citationTakahashi, K., Saitoh, A., Yamada, M., Maruyama, Y., Hirose, N., Kamei, J., & Yamada, M. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08149fp · Cited by 15
κ‐ opioid receptors are not necessary for the antidepressant treatment of neuropathic pain
Megat, S., Bohren, Y., Doridot, S., Gavériaux‐Ruff, C., Kieffer, B. L., Freund‐Mercier, M. J., Yalçın, İ., & Barrot, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12963 · Cited by 14
Self-citationChabot‐Doré, A., Millecamps, M., & Stone, L. S. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.206581 · Cited by 13
Posa, L., Gregorio, D. D., López-Canul, M., He, Q., Darcq, E., Rullo, L., Pearl‐Dowler, L., Luongo, L., Candeletti, S., Romualdi, P., et al. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12825 · Cited by 13
Self-citationWand, G. S., Weerts, E. M., Kuwabara, H., Wong, D. F., Xu, X., & McCaul, M. E. (2012) · Alcohol · doi:10.1016/j.alcohol.2012.04.006 · Cited by 13
The Continuum Between Temperament and Mental Illness as Dynamical Phases and Transitions
Sulis, W. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.614982 · Cited by 13
Discontinued anxiolytic drugs (2009 – 2014)
Mandrioli, R., & Mercolini, L. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.998335 · Cited by 14
Plasma metabolites were associated with spatial working memory in major depressive disorder
Du, Y., Wei, J., Yang, X., Dou, Y., Zhao, L., Qi, X., Yu, X., Guo, W., Wang, Q., Deng, W., et al. (2021) · Medicine · doi:10.1097/md.0000000000024581 · Cited by 13
Demirkapu, M. J., & Yananlı, H. R. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91326 · Cited by 13
Rodgers, G. H., Hubert, C., McKinzie, J. H., Suter, T. M., Statnick, M. A., Emmerson, P. J., & Stancato, L. F. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803770380986 · Cited by 13
Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder
Hampsey, E., Jelen, L. A., & Young, A. H. (2024) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2024.2345645 · Cited by 12
A Functional Approach to Deconvolve Dynamic Neuroimaging Data
Jiang, C., Aston, J. A. D., & Wang, J.-L. (2015) · Journal of the American Statistical Association · doi:10.1080/01621459.2015.1060241 · Cited by 17
Neuropeptide and cytokine regulation of pain in the context of substance use disorders
Delery, E., & Edwards, S. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108153 · Cited by 12
Behavioral effects evoked by the beta globin-derived nonapeptide LVV-H6
da Cruz, K. R., Ianzer, D. A., Turones, L. C., Reis‐Silva, L. L., Camargo-Silva, G., Mendonça, M. M., da Silva, E. S., Pedrino, G. R., Castro, C. H., Costa, É. A., et al. (2019) · Peptides · doi:10.1016/j.peptides.2019.03.002 · Cited by 12
Borkowski, A. H., Barnes, D. C., Blanchette, D. R., Castellanos, F. X., Klein, D. F., & Wilson, D. A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.042 · Cited by 12
Quantitative autoradiography of dopamine receptors in the brains of μ-opioid receptor knockout mice
Léna, I., Matthes, H. W. D., Kieffer, B. L., & Kitchen, I. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.058 · Cited by 15
Self-citationCalcium activated adenylyl cyclase AC8 but not AC1 is required for prolonged behavioral anxiety
Bernabucci, M., & Zhuo, M. (2016) · Molecular Brain · doi:10.1186/s13041-016-0239-x · Cited by 11
Opiorphin: an endogenous human peptide with intriguing application in diverse range of pathologies
Tiwari, C., Khan, H., Grewal, A. K., Dhankhar, S., Chauhan, S., Dua, K., Gupta, G., & Singh, T. G. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01526-8 · Cited by 11
Antidepressants and the endogenous opioid system
Fricker, L. D., Osman, A., Gupta, A., Gomes, I., & Devi, L. A. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117392 · Cited by 12
Roques, B. P. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_17 · Cited by 12
Xu, W., Chen, C., Li, J., DiMattio, K. M., Wang, Y., Unterwald, E. M., & Liu‐Chen, L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.04.006 · Cited by 11
In Vivo Techniques to Investigate the Internalization Profile of Opioid Receptors
Pradhan, A. A. A., Tawfik, V. L., Tipton, A. F., & Scherrer, G. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1708-2_7 · Cited by 11
Moine, C. L., Fauchey, V., & Jaber, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00014-3 · Cited by 11
Antinociceptive and anti-inflammatory activities of leaf extracts from Annona tomentosa R.E.Fr
Carneiro, L. U., da Silva, I. G., de Souza, M. E. A., Côrtes, W. D. S., de Carvalho, M. G., & Marinho, B. G. (2017) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(17)60349-2 · Cited by 12
Gibuła‐Tarłowska, E., Marszałek‐Grabska, M., Witkowska, E., Izdebski, J., & Kotlinska, J. H. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.01.007 · Cited by 13
Quentin, T., Debruyne, D., Lelong‐Boulouard, V., Poisnel, G., Barré, L., & Coquerel, A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.09.013 · Cited by 11
University of Veterinary Medicine Hannover
Komm, K. (2010) · Cited by 11
Chen, C., Ding, H., Mabry, K. M., & Ko, M. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173341 · Cited by 10
The Contribution of Mosaic Chromosomal Alterations to Schizophrenia
Chang, K., Jian, X., Wu, C., Gao, C., Li, Y., Chen, J., Xue, B., Ding, Y., Peng, L., Wang, B., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.06.015 · Cited by 10
Role of DOR in neuronal plasticity changes promoted by food-seeking behaviour
Mancino, S., Mendonça-Netto, S., Martín‐García, E., & Maldonado, R. J. (2016) · Addiction Biology · doi:10.1111/adb.12401 · Cited by 11
Self-citationGranholm, L., Segerström, L., & Nylander, I. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00425 · Cited by 10
La découverte de l’opiorphine humaine: Un modulateur anti-nociceptif des voies opioïdergiques
Rougeot, C., & Messaoudi, M. (2007) · médecine/sciences · doi:10.1051/medsci/200723137 · Cited by 10
(2013) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.1000122 · Cited by 10
Brissett, D. I., Whistler, J. L., & van Rijn, R. M. (2011) · European Journal of Pain · doi:10.1002/j.1532-2149.2011.00022.x · Cited by 12
Yoo, J., Bailey, A., Borsodi, A. D., Tóth, G., Matifas, A., Kieffer, B. L., & Kitchen, I. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.007 · Cited by 10
Self-citationChapter 4.1 Peptide receptor ligands to treat anxiety disorders
Steckler, T. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00010-0 · Cited by 13
Opioid Receptor-Induced GTPγ35S Binding during Mouse Development
Nitsche, J. F., & Pintar, J. E. (2003) · Developmental Biology · doi:10.1006/dbio.2002.0855 · Cited by 10
Metadata
- Authors
- Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., Valverde, O., Maldonado, R., & Kieffer, B. L.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Universitat Pompeu Fabra (ES)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Corresponding author
- Kieffer, Brigitte L.
- ORCID
- Venue
- Nature Genetics
- Published
- 2000-06
- Volume
- 25
- Issue
- 2
- Pages
- 195-200
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1505495051
- Cited by
- 672
- References
- 31
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 19 · 2022: 18 · 2021: 16 · 2020: 24 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 41 · 2015: 24 · 2014: 39 · 2013: 35 · 2012: 33
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- delta opioid receptor, mu-opioid receptor, kappa opioid receptor, OprM, anxiety-like behavior, depression-like behavior, emotion regulation, mood disorders, drug addiction, pain
- MeSH terms
- Animals, Anxiety, Binding Sites, Darkness, Depression, Electroshock, Female, Light, Male, Motor Activity, Naloxone, Naltrexone, Narcotic Antagonists, Phenotype, Sex Characteristics, Swimming, Pain Threshold, Gene Deletion, Receptors, Opioid, mu, Receptors, Opioid, delta, Receptors, Opioid, kappa, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.